Digging into March-In: Appealing Concept for Some, But Anathema to Others

Fresh Look at History and Current Issues

Marching in to seize the rights to a seemingly miraculous therapy that has been relegated to a dark shelf in some mammoth or not-so-mammoth biomedical firm has some appeal to frustrated patients and others deeply concerned about saving lives. 

The reality is somewhat different. 

A long look at the situation surfaced this morning in Washington, D.C., which…